Nanotechnology and its relationship to interventional radiology. Part I: Imaging

CardioVascular and Interventional Radiology

Volumn 34, Issue 2, 2011, Pages 221-226

  Power, Sarah ^a   Slattery, Michael M ^a   Lee, Michael J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Angiogenesis; Imaging; Interventional radiology; Nanoparticle; Nanotechnology; Restenosis

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; CONTRAST MEDIUM; GADOLINIUM; IODINE; LIPOSOME; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG TARGETING; HUMAN; HYPERTHERMIC THERAPY; INTERVENTIONAL RADIOLOGY; LOW DRUG DOSE; LYMPH NODE METASTASIS; MACROPHAGE; MOLECULAR IMAGING; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RESTENOSIS; REVIEW;

ATHEROSCLEROSIS; CORONARY RESTENOSIS; HUMANS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; NANOTECHNOLOGY; RADIOLOGY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955556753     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-010-9961-4     Document Type: Review

References (53)

1. JH Rundback K Wright G McLennan, et al. 2003 Current status of interventional radiology research: results of a CIRREF survey and implications for future research strategies J Vasc Interv Radiol 14 1103 1110 (Pubitemid 37193723)
2. A Meullner GM Glazer MF Reiser, et al. 2009 Advancing radiology through informed leadership: summary of the proceedings of the seventh biannual symposium of the international society for strategic studies in radiology (IS3R), 23-25 August 2007 Eur Radiol 19 1827 1836 10.1007/s00330-009-1370-1
3. SF Millward JF Cardella A Hsiao 2009 Emerging technologies articles J Vasc Interv Radiol 20 Suppl 7 S487 10.1016/j.jvir.2009.04.052
4. SN Goldberg B Joseph D Gerald, et al. 2005 Society of Interventional Radiology Interventional Oncology Task Force: interventional oncology research vision statement and critical assessment of the state of research affairs J Vasc Interv Radiol 16 1287 1294 (Pubitemid 41463985)
5. Ratner M, Ratner D (2003) Nanotechnology: a gentle introduction to the next big idea. Prentice Hall, Upper Saddle River
6. JH Thrall 2004 Nanotechnology and medicine Radiology 230 315 318 10.1148/radiol.2302031698 (Pubitemid 38133784)
7. WCW Chan 2006 Bionanotechnology progress and advances Biol Blood Marrow Transplant 12 87 91 10.1016/j.bbmt.2005.10.004 1:CAS:528:DC%2BD28XitVGksrY%3D (Pubitemid 43034126)
8. N Iverson N Plourde E Chnari, et al. 2008 Convergence of nanotechnology and cardiovascular medicine: progress and emerging prospects Biodrugs 22 1 10 10.2165/00063030-200822010-00001 1:CAS:528:DC%2BD1cXltl2rtr0%3D (Pubitemid 351158530)
9. RA Freitas 2005 What is nanomedicine? Nanomedicine 1 2 9 1:CAS:528:DC%2BD2MXlvVSrurs%3D
10. S Nie Y Xing GJ Kim, et al. 2007 Nanotechnology applications in cancer Annu Rev Biomed Eng 9 257 288 10.1146/annurev.bioeng.9.060906.152025 1:CAS:528:DC%2BD2sXhtVehtLbK (Pubitemid 350246658)
11. A Luciani C Wilhelm P Bruneval, et al. 2009 Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver Eur Radiol 19 1087 1096 10.1007/s00330-008-1262-9
12. JM Provenzale GA Silva 2009 Uses of nanoparticles for central nervous system imaging and therapy Am J Neuroradiol 30 1293 1301 10.3174/ajnr.A1590 1:STN:280:DC%2BD1MrksVWktg%3D%3D
13. J Zhou C Leuschner C Kumar, et al. 2006 Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases Biomaterials 27 2001 2008 10.1016/j.biomaterials.2005.10.013 1:CAS:528:DC%2BD2MXht12isLfM (Pubitemid 41759493)
14. A Moore E Marecos A Bogdanov, et al. 2000 Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model Radiology 214 568 574 1:CAS:528:DC%2BD3cXpvF2rtw%3D%3D (Pubitemid 30077721)
15. B Chertok BA Moffat AE David, et al. 2008 Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumours Biomaterials 29 487 496 10.1016/j.biomaterials.2007.08.050 1:CAS:528: DC%2BD2sXhtlWmsrjN (Pubitemid 350100794)
16. M Kresse S Wagner D Pfefferer, et al. 1998 Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways Magn Reson Med 40 236 242 10.1002/mrm.1910400209 1:CAS:528:DyaK1cXlsVSjtLw%3D (Pubitemid 28361526)
17. 3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging Cancer Res 63 5838 5843 1:CAS:528:DC%2BD3sXnvVSjuro%3D (Pubitemid 37187482)
18. C Wyss SC Schaefer L Juillerat-Jeanneret, et al. 2009 Molecular imaging by micro-CT: specific E-selectin imaging Eur Radiol 19 2487 2494 10.1007/s00330-009-1434-2
19. MG Harishinghani J Barentsz PF Hahn, et al. 2003 Noninvasive detection of clinically occult lymph node metastases in prostate cancer N Engl J Med 348 25 2491 2499 10.1056/NEJMoa022749 (Pubitemid 36706536)
20. H Nishimura N Tanigawa M Hiramatsu, et al. 2006 Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide J Am Coll Surg 202 604 611 10.1016/j.jamcollsurg.2005.12.004
21. TW Stadnik H Everaert S Makkat, et al. 2006 Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging - Initial findings Eur Radiol 16 2153 2160 10.1007/s00330-006-0276-4 (Pubitemid 44354549)
22. SC Michel TM Keller JM Fröhlich, et al. 2002 Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement Radiology 225 527 536 10.1148/radiol.2252011605 (Pubitemid 35239258)
23. MJ Lahaye SM Engelen AG Kessels, et al. 2008 USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria Radiology 246 804 811 10.1148/radiol.2463070221
24. S Motoyama K Ishiyama K Maruyama, et al. 2007 Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer Surgery 141 736 747 10.1016/j.surg.2007.01.032 (Pubitemid 46856581)
25. C Corot P Robert J Idée, et al. 2006 Recent advances in iron oxide nanocrystal technology for medical imaging Adv Drug Deliv Rev 58 1471 1504 10.1016/j.addr.2006.09.013 1:CAS:528:DC%2BD28Xht1KmtLbP (Pubitemid 44820503)
26. DLJ Thorek AK Chen J Czupryna, et al. 2006 Superparamagnetic iron oxide nanoparticle probes for molecular imaging Ann Biomed Eng 34 23 38 10.1007/s10439-005-9002-7
27. YX Wang SM Hussain GP Krestin 2001 Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging Eur Radiol 11 2319 2331 10.1007/s003300100908 1:STN:280:DC%2BD3MnkvVygsA%3D%3D (Pubitemid 33041104)
28. O Will S Purkayastha C Chan, et al. 2005 Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis Lancet Oncol 7 52 60 10.1016/S1470-2045(05)70537-4
29. M Harishinghani 2008 Nanoparticle-enhanced MRI: are we there yet? Lancet Oncol 9 814 815 10.1016/S1470-2045(08)70215-8
30. WS Enochs G Harsh F Hochberg, et al. 1999 Improved delineation of human brain tumors on MR images using a long-circulating, superparamagnetic iron oxide agent J Magn Reson Imaging 9 228 232 10.1002/(SICI)1522-2586(199902)9:2<228: :AID-JMRI12>3.0.CO;2-K 1:STN:280:DyaK1M7nsVKgtA%3D%3D (Pubitemid 29115346)
31. Y Matsumura H Maeda 1986 A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumour agents Smancs Cancer Res 46 6387 6392 1:CAS:528:DyaL2sXnvVensA%3D%3D (Pubitemid 17221789)
32. H Maeda J Wu T Sawa, et al. 2000 Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 1-2 271 284 10.1016/S0168-3659(99)00248-5 1:CAS:528:DC%2BD3cXhtl2qsLo%3D (Pubitemid 30122932)
33. H Choi SR Choi R Zhou, et al. 2004 Iron oxide nanoparticles as magnetic resonance contrast agent for tumour imaging via folate receptor-targeted delivery Acad Radiol 11 996 1004 10.1016/j.acra.2004.04.018 (Pubitemid 39220809)
34. TJ Chen TH Cheng YC Hung, et al. 2008 Targeted folic acid-PEG nanoparticles for noninvasive imaging of folate receptor by MRI J Biomed Mater Res A 87 165 175
35. ZJ Wang S Boddington M Wendland, et al. 2008 MR Imaging of ovarian tumors using folate-receptor-targeted contrast agents Pediatr Radiol 38 529 537 10.1007/s00247-008-0764-6 1:CAS:528:DC%2BD1cXosVGgu70%3D
36. D Högemann-Savellano E Bos C Blondet, et al. 2003 The transferrin receptor: a potential molecular imaging marker for human cancer Neoplasia 5 495 506 (Pubitemid 38045087)
37. I Bertini F Bianchini L Calorini, et al. 2004 Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma Magn Reson Med 52 669 672 10.1002/mrm.20189 1:CAS:528:DC%2BD2cXnvFWrs7w%3D (Pubitemid 39108982)
38. MO Oyewumi RA Yokel M Jay, et al. 2004 Comparison of cell uptake, biodistribution, and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor bearing mice J Control Release 95 613 626 10.1016/j.jconrel.2004.01.002 1:CAS:528:DC%2BD2cXitVKgtL4%3D (Pubitemid 38340510)
39. O Rabin JM Perez J Grimm, et al. 2006 An x-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles Nat Mater 5 118 122 10.1038/nmat1571 1:CAS:528:DC%2BD28XptFOgsg%3D%3D (Pubitemid 43177900)
40. P Libby 2006 Inflammation and cardiovascular disease mechanisms Am J Clin Nutr 83 456S 460S 1:CAS:528:DC%2BD28Xhs1ehsro%3D
41. PR Moreno E Falk IF Palacios, et al. 1994 Macrophage infiltration in acute coronary syndromes: implications for plaque rupture Circulation 90 775 778 1:STN:280:DyaK2czitVamsA%3D%3D (Pubitemid 24242744)
42. SG Ruehm C Corot P Vogt, et al. 2001 Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidaemic rabbits Circulation 103 415 422 1:CAS:528: DC%2BD3MXhtF2ksbk%3D (Pubitemid 32105982)
43. F Hyafil JP Laissy M Mazighi, et al. 2006 Ferumoxtran-10-enhanced MRI of the hypercholesterolaemic rabbit aorta: relationship between signal loss and macrophage infiltration Arterioscler Thromb Vasc Biol 26 176 181 10.1161/01.ATV.0000194098.82677.57 1:CAS:528:DC%2BD2MXhtlagt7jO (Pubitemid 43732246)
44. ME Kooi VC Cappendijk KB Cleutjens, et al. 2003 Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging Circulation 107 2453 2458 10.1161/01.CIR.0000068315.98705.CC 1:CAS:528:DC%2BD3sXjs1antb8%3D (Pubitemid 36605228)
45. RA Trivedi JM U-King-Im MJ Graves, et al. 2004 Noninvasive imaging of carotid plaque inflammation Neurology 63 187 188 1:STN:280: DC%2BD2czks1OjtA%3D%3D (Pubitemid 38943809)
46. RA Trivedi JM U-King-Im MJ Graves, et al. 2004 In vivo detection of macrophages in human carotid atheroma: temporal dependance of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI Stroke 35 1631 1635 10.1161/01.STR.0000131268.50418.b7 (Pubitemid 38823638)
47. TY Tang SPS Howarth SR Miller, et al. 2009 The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study: evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease J Am Coll Cardiol 53 2039 2050 10.1016/j.jacc.2009.03.018 1:CAS:528:DC%2BD1MXotFOltrY%3D
48. A Tsourkas VR Shinde-Patil KA Kelly, et al. 2005 In vivo imaging of activated endothelium using an Anti-VCAM-1 magneto optical probe Bioconjug Chem 16 576 581 10.1021/bc050002e 1:CAS:528:DC%2BD2MXjs1Sit7g%3D (Pubitemid 40696049)
49. KA Kelly JR Allport A Tsourkas, et al. 2005 Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle Circ Res 96 327 336 10.1161/01.RES.0000155722.17881.dd 1:CAS:528:DC%2BD2MXhtF2nsL0%3D (Pubitemid 40279907)
50. PR Moreno KR Purushothaman V Fuster, et al. 2004 Plaque neovascularisation is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability Circulation 110 2032 2038 10.1161/01.CIR.0000143233.87854.23 (Pubitemid 39331918)
51. PM Winter AM Morawski SD Caruthers, et al. 2003 Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles Circulation 108 2270 2274 10.1161/01.CIR.0000093185.16083.95 1:CAS:528:DC%2BD3sXosVShs7c%3D (Pubitemid 37363046)
52. 3-integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arterioscler Thromb Vasc Biol 26 2103 2109 10.1161/01.ATV.0000235724.11299.76 1:CAS:528:DC%2BD28XotVWlt78%3D (Pubitemid 44253795)
53. GM Lanza PM Winter X Yu, et al. 2002 Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis Circulation 106 2842 2847 10.1161/01.CIR.0000044020.27990.32 1:CAS:528:DC%2BD38XoslSnsb0%3D (Pubitemid 35396985)